Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

NUVB

NYSE

Nuvation Bio (NUVB)

5.84 USD −3.95% vs prior close Sep 18, 2026
Nuvation Bio Inc. price graph
19 sessions
7.5 5.5 24 Aug 18 Sep

The line runs 6.77 USD on 24 August through 5.84 USD on 18 September, on a scale from 5.5 to 7.5. Days the market did not trade hold the previous close, flat.

Market cap
2.1B USD
Revenue, year to Dec 2025
62.9M USD
EPS, diluted, year to Dec 2025
−0.60 USD
52-week range
3 USD – 9.53 USD
Avg volume
391.3K

as of Sep 18, 2026

Have Nuvation Bio (NUVB) insiders bought or sold shares recently?

NUVB's newest Form 4 filing is dated 19 August 2026: none in the last 90 days.

Form 4

Have Nuvation Bio (NUVB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
19 Aug 2026Hattersley GaryCHIEF SCIENTIFIC OFFICERSell100,000709K USD
23 Jun 2026Markel StacyCHIEF PEOPLE OFFICERSell125,000753K USD
23 Jun 2026Wentworth KerryCHIEF REGULATORY OFFICERSell63,000379K USD
23 Jun 2026Sauvage PhilippeChief Financial OfficerSell47,668286K USD
09 Jun 2026Mashal RobertDirectorBuy25,000118K USD
17 Apr 2026Liu DongfangCHIEF MEDICAL OFFICERSell50,000251K USD
17 Apr 2026Wentworth KerryCHIEF REGULATORY OFFICERSell36,750184K USD
06 Apr 2026Wentworth KerryCHIEF REGULATORY OFFICERSell200,000904K USD
01 Dec 2025Liu DongfangCHIEF MEDICAL OFFICERSell150,0001.2M USD
26 Nov 2025Liu DongfangCHIEF MEDICAL OFFICERSell10,00080K USD
25 Nov 2025Liu DongfangCHIEF MEDICAL OFFICERSell10,00075K USD
20 Nov 2025Hattersley GaryCHIEF SCIENTIFIC OFFICERSell369,0512.7M USD
Bought1 open-market purchase25,000$118K
Sold16 open-market sales1,511,469$9.68M

Showing the 12 most recent of 17 open-market trades in this window. The figures above count all of them.

18 other filings: grants, exercises, tax withholding and transfers, not trades
Have Nuvation Bio (NUVB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
19 Aug 2026Hattersley GaryCHIEF SCIENTIFIC OFFICEROption exercise100,000187K USD
15 Jul 2026Sauvage PhilippeChief Financial OfficerOption exercise40,00087K USD
23 Jun 2026Markel StacyCHIEF PEOPLE OFFICEROption exercise125,000229K USD
23 Jun 2026Wentworth KerryCHIEF REGULATORY OFFICEROption exercise63,000185K USD
23 Jun 2026Sauvage PhilippeChief Financial OfficerOption exercise47,668103K USD
17 Apr 2026Liu DongfangCHIEF MEDICAL OFFICEROption exercise50,00097K USD
17 Apr 2026Wentworth KerryCHIEF REGULATORY OFFICEROption exercise36,750108K USD
06 Apr 2026Wentworth KerryCHIEF REGULATORY OFFICEROption exercise200,000381K USD
27 Feb 2026Makunje MosesSEE REMARKSAward50,761
01 Dec 2025Liu DongfangCHIEF MEDICAL OFFICEROption exercise150,000440K USD
26 Nov 2025Liu DongfangCHIEF MEDICAL OFFICEROption exercise10,00036K USD
25 Nov 2025Liu DongfangCHIEF MEDICAL OFFICEROption exercise10,00036K USD

Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.

Which funds hold Nuvation Bio (NUVB)?

11 of the 45 institutional funds we track reported a Nuvation Bio position for the quarter ended 30 Sep 2026 — a combined 82.0M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Nuvation Bio (NUVB)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsAdded3,300,30318.5M USD+164.4%
AQR Capital ManagementHeld (±25%)2,508,29614.0M USD+6.4%
Citadel AdvisorsHeld (±25%)2,371,00913.3M USD+19.2%
Duquesne Family OfficeTrimmed2,269,90012.7M USD−50.0%
Renaissance TechnologiesHeld (±25%)1,319,6957.4M USD−2.0%
D. E. Shaw & Co.Held (±25%)903,3105.1M USD−20.8%
Millennium ManagementAdded700,1963.9M USD+87.8%
Man GroupAdded695,4543.9M USD+69.4%
Marshall WaceAdded283,5361.6M USD+240.0%
Tudor Investment CorpNew position267,0321.5M USD

Showing the 10 largest of 11 reported positions. The figures above count all of them.

What has been filed or recorded for Nuvation Bio (NUVB)?

The filings we hold for Nuvation Bio, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 23 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Nuvation Bio (NUVB)?
And
23 Oct 2026Fails to deliverShares failed to deliver1,087,115 shares5.1M USD notional · 0.308% of shares out
19 Oct 2026Fails to deliverShares failed to deliver200 shares890 USD notional · <0.001% of shares out
16 Oct 2026Fails to deliverShares failed to deliver11,097 shares53K USD notional · 0.003% of shares out
15 Oct 2026Fails to deliverShares failed to deliver44,606 shares209K USD notional · 0.013% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.12 USDRevenue $45M
30 Sep 2026FinancialsTotal assets778.4M USDat period end
30 Sep 2026FinancialsTotal equity228.0M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.18 USDRevenue $32M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.01 USDRevenue $83M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.60 USDRevenue $63M
31 Dec 2025FinancialsRevenue62.9M USDfiscal year
31 Dec 2025FinancialsNet income−204.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.60 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.16 USDRevenue $13M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.17 USDRevenue $5M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.16 USDRevenue $3M
31 Dec 2024Annual reportFY 2024 reportedEPS −2.11 USDRevenue $8M

What do people ask about Nuvation Bio (NUVB)?

From live data
What did Nuvation Bio shares close at?5.84

Nuvation Bio closed at 5.84 USD on 18 Sep 2026, down 3.95% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Nuvation Bio’s market cap?2.1B

Nuvation Bio is worth 2.1B USD by market value as of 18 Sep 2026, which is the share price times the shares on issue from its SEC filings.

What is Nuvation Bio’s revenue?62.9M

Nuvation Bio reported revenue of 62.9M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Nuvation Bio insiders bought or sold shares recently?

No Nuvation Bio insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 19 Aug 2026 (SEC Form 4). See Insiders

Which funds own Nuvation Bio?11 of 45

11 of the 45 funds we track reported a Nuvation Bio position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, AQR Capital Management and Citadel Advisors. See Funds

When did Nuvation Bio last report earnings?−0.12

Nuvation Bio last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.12 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words